The Food and Drug Administration released its most recent list of drugs that consumers and health professionals should keep their eye on due to serious risks or new safety information.
One of the drugs on this quarterly list includes Savella (Milnacipran HCI), which is used to treat fibromyalgia - a disease that causes widespread pain to the muscles, joints, tendons and other soft tissues, according to the National Center for Biotechnology Information.
Savella is on the watch list because of its association with patients experiencing homicidal ideation. The FDA is evaluating this issue to determine if regulatory action is necessary.
The FDA used the information from the Adverse Event Reporting System (AERS) database from October to December 2011 to identify the new hazards and safety data for the drugs. An appearance of a medication on the list is an indication that there is a potential safety issue, but does not mean there is a cause and effect relationship between the drug and risk.